New Advances in Biology and Treatment
Part of the Corporate Friday Program prior to the ASH Annual Meeting
(Sponsored by the Strategic Institute for Continuing Health Care Education)
December 3, 1999
New Orleans, LA
This CME activity was intended for hematologists and oncologists.
At the conclusion of the conference, participants should be able to:
- Summarize the latest clinical trial results on the treatment of myeloma bone disease.
- Describe the epidemiology and pathogenesis of multiple myeloma, including the emerging role of a viral etiology.
- Explain the role of cytokines in bone destruction.
- Discuss both conventional therapy and innovative treatments for the clinical management of bone disease